Michael McCartney
Nessuna posizione attualmente
Profilo
Michael McCartney served as the Chief Executive Officer of SciKon Innovation, Inc. from 2017 to 2018.
Prior to that, he was the Chief Commercial Officer at Cancer Genetics, Inc. and Vyant Bio, Inc. McCartney received an undergraduate degree from Indiana University of Pennsylvania and an MBA from LaSalle University.
Precedenti posizioni note di Michael McCartney
| Società | Posizione | Fine |
|---|---|---|
| SciKon Innovation, Inc. | Amministratore Delegato | 01/05/2018 |
| VYANT BIO, INC. | Corporate Officer/Principal | - |
| CANCER GENETICS, INC. | Corporate Officer/Principal | - |
Formazione di Michael McCartney
| Indiana University of Pennsylvania | Undergraduate Degree |
| LaSalle University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| VYANT BIO, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Cancer Genetics, Inc.
 Cancer Genetics, Inc. Medical SpecialtiesHealth Technology Cancer Genetics, Inc. engages in the development, commercialization, and sale of molecular and biomarker-based tests and services. Through its Select One Clinical Trials program, the firm provides a range of clinical trial services for both oncology and non-oncology genetic testing such as bioinformatics, biomarker solutions, bio repository solutions, consulting, cytogenetic testing, nucleic acid extraction and purification, flow cytometry, Focus: NGS Panel, gene expression analyses, genotyping, and pharmacogenomics. The company was founded by Raju S. K. Chaganti on April 8, 1999 and is headquartered in Rutherford, NJ. | Health Technology |
| SciKon Innovation, Inc. |
- Borsa valori
- Insiders
- Michael McCartney
